Stage IV Lung Cancer Clinical Trial
Official title:
A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer
This pilot clinical trial studies the feasibility and effectiveness of a new computer-based communication intervention in supporting distance caregivers of patients with advanced lung or brain cancer. Unlike local caregivers, distance caregivers often receive little, if any, professional support and have limited communication with the oncology team. Using a computer-based communication intervention to allow distance caregivers the opportunity to participate in a physician visit, have questions and concerns addressed, and meet members of the oncology team may help reduce stress.
PRIMARY OBJECTIVES:
I. What is the relationship of primary stressors (type and stage/grade of cancer, and
patient quality of life [QOL]) and structural factors/stressors (age, gender, race, and
education) with patient and caregiver psychological outcomes at baseline? II. What are the
effects of the Communication with Long Distance Caregivers Offering a Supportive Electronic
Resource (CLOSER) intervention on distance caregiver psychological outcomes (anxiety and
distress), controlling for primary stressors (type and stage/grade of cancer, and patient
quality of life), distance caregiver structural factors/stressors (caregiver age, gender,
race, and employment), and baseline anxiety and distress? III. What are the effects of the
CLOSER intervention on patient psychological outcomes (anxiety and distress), controlling
for primary stressors (type and stage/grade of cancer, and patient quality of life),
distance caregiver structural factors/stressors (caregiver age, gender, race, and
employment), and baseline anxiety and distress? IV. What is the feasibility (time, cost,
resources and acceptability to patients, caregivers and clinicians) of using Adobe Connect,
a computer-based web communication system, with the distance caregiver, the parent with
advanced cancer, and the health care providers together in a routine follow-up oncology
office visit? V. What is the experience of being a distance caregiver participating in the
CLOSER intervention?
OUTLINE: Participants are assigned to 1 of 2 arms.
ARM I: Participants receive usual care for 5 weeks. During the week 5 office visit, distance
caregivers are not present.
ARM II: Participants receive usual care for 5 weeks. During the week 5 visit, distance
caregivers virtually attend using the CLOSER intervention with computer video and audio
connection.
After completion of study, participants are followed up within 48-96 hours.
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01228435 -
IPI-504 in NSCLC Patients With ALK Translocations
|
Phase 2 | |
| Completed |
NCT00579215 -
Lung Cancer Informational Study (LCIS)
|
N/A | |
| Completed |
NCT01556191 -
Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR
|
Phase 2 | |
| Terminated |
NCT00003495 -
Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
|
Phase 2 | |
| Terminated |
NCT00003491 -
Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT03867175 -
Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer
|
Phase 3 | |
| Not yet recruiting |
NCT04985357 -
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs
|
||
| Recruiting |
NCT06110572 -
Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04267575 -
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites
|
N/A | |
| Not yet recruiting |
NCT06383988 -
A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources
|
N/A | |
| Completed |
NCT02606149 -
Truthful Information on Chemotherapy and Its Impact on Chemotherapy at the End of Life
|
N/A | |
| Completed |
NCT02693080 -
CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy
|
Phase 1 | |
| Completed |
NCT02318771 -
Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer
|
Phase 1 | |
| Terminated |
NCT04005144 -
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer
|
Phase 1 | |
| Completed |
NCT03112668 -
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners
|
N/A | |
| Completed |
NCT03222258 -
Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients
|
||
| Completed |
NCT05025748 -
Ask Questions (ASQ):Implementation of a Communication Intervention
|
N/A | |
| Recruiting |
NCT05435846 -
Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation
|
Phase 1 | |
| Terminated |
NCT02109016 -
A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations
|
Phase 2 | |
| Terminated |
NCT00003492 -
Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
|
Phase 2 |